At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drives engagement—and how a new dual sensor readies pharmacists for ketone alerts.

Phase 3 HARMONi-2 interim analysis shows first bispecific PD-1/VEGF antibody outperforming standard immunotherapy in first-line NSCLC.

Vicki Saengkheune, PharmD, and Bola Olagunju, PharmD, describe a collaborative clinic where pharmacists titrate therapy, counsel, and remove access barriers.

Apitegromab-mstn is cleared as an add-on to SMN2-targeted treatment for patients aged 2 and older, directly addressing muscle loss.

With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.

Jackie Burke, PharmD, has advice for strengthening collaborative drug therapy management (CDTM) in a year: ask leaders what they need, then pilot one focused, trackable, reportable workflow.